Does FEDRATINIB Cause Myelofibrosis? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Myelofibrosis have been filed in association with FEDRATINIB (Inrebic). This represents 1.0% of all adverse event reports for FEDRATINIB.
14
Reports of Myelofibrosis with FEDRATINIB
1.0%
of all FEDRATINIB reports
4
Deaths
3
Hospitalizations
How Dangerous Is Myelofibrosis From FEDRATINIB?
Of the 14 reports, 4 (28.6%) resulted in death, 3 (21.4%) required hospitalization.
Is Myelofibrosis Listed in the Official Label?
Yes, Myelofibrosis is listed as a known adverse reaction in the official FDA drug label for FEDRATINIB.
What Other Side Effects Does FEDRATINIB Cause?
Diarrhoea (143)
Death (138)
Nausea (114)
Fatigue (105)
Vomiting (74)
Constipation (59)
Platelet count decreased (48)
Asthenia (47)
Haemoglobin decreased (46)
Full blood count decreased (45)
What Other Drugs Cause Myelofibrosis?
RUXOLITINIB (1,316)
ELTROMBOPAG (89)
ROMIPLOSTIM (89)
HYDROXYUREA (88)
IMATINIB (76)
DEFERASIROX (57)
MOMELOTINIB (51)
ASPIRIN (46)
RITUXIMAB (43)
ANAGRELIDE (41)
Which FEDRATINIB Alternatives Have Lower Myelofibrosis Risk?
FEDRATINIB vs FELBAMATE
FEDRATINIB vs FELIS CATUS HAIR
FEDRATINIB vs FELODIPINE
FEDRATINIB vs FENFLURAMINE
FEDRATINIB vs FENOFIBRATE